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HISTOPATHOLOGY, SEROLOGY AND CULTURES IN THE DIAGNOSIS OF CRYPTOCOCCOSIS
Alexandra Flávia GAZZONI(1), Cecília Bittencourt SEVERO(2,3), Emily Ferreira SALLES(2,4) & Luiz Carlos SEVERO(3,5,6)
SUMMARY
Cryptococcosis is one of the most common opportunistic fungal infections in patients with acquired immunodeficiency syndrome 
(AIDS). We report 13 cases of cryptococcal infection based on histopathology, serology and cultures. Epidemiological analysis, 
histochemical techniques of hematoxilin and eosin (HE) and Grocot’s silver (GMS), as well special histochemical techniques such as 
Mayer’s mucicarmine (MM) and Fontana-Masson (FM), cryptococcal antigen test (CrAg) and isolation on fungal media: Sabouraud’s 
(SAB), brain-heart infusion agar (BHI) and canavanine-glycine-bromothymol blue (CGB) agar were analyzed. Unsatisfactory staining 
results by MM stain associated to negative titers by CrAg test, which FM stain confirmed that capsule-deficient Cryptococcus infections 
were observed in four cases. Eight isolated cases were identified as follows: six cases were infection with Cryptococcus neoformans 
and two cases were Cryptococcus gattii.
KEYWORDS: Budding index; Carminophilic index; Mayer’s mucicarmine stain; Fontana-Masson stain; Cryptococcal antigen test; 
Cultures.
INTRODUCTION
Cryptococcosis is a systemic infection caused by naturally 
encapsulated basidiomycetous of genus Cryptococcus7,13. This yeast 
causes human infection ranging from asymptomatic pulmonary 
colonization to meningitis and disseminated disease6. Cryptococcosis is 
caused by two species: Cryptococcus gattii is typically found in tropical 
and subtropical climates zones, and usually causes disease in apparently 
normal hosts5,8,23,25, whereas the C. neoformans present in urban pigeon 
droppings, has a worlwide distribution and is a common opportunistic 
infection5,6,23,25. Specifically, conditions predisposing to a change in 
cellular immunity have been associated with a significant increase in 
risk to obtain the cryptococcosis, and these include lymphoproliferative 
disorders, organ transplantation, and receiving immunosuppressive 
therapy23. Cryptococcosis is also one of the most common opportunistic 
fungal infections in acquired immunodeficiency syndrome (AIDS) 
patients, and, in that group, it is associated with a high mortality rate23. 
Microscopically, Cryptococcus has spherical to oval yeast cells, 5-10 
mm in diameter that are surrounded by a polysaccharide capsule2,7, which 
is a major virulence factor and the substrate detected by cryptococcal 
antigen tests (CrAg)4,7. However, capsule-deficient Cryptococcus 
infections may result in false-negative results using the CrAg test13,15,29.
Cryptococcosis laboratory diagnosis includes conventional 
methods (direct microscopic examination and histopathology)5,11,12,13, 
usually associated to serology3,4,20 and to isolation of the organism in 
culture3,5,23. Histopathologic identification in biopsy specimens is based 
on the micromorphological characteristics of Cryptococcus, and include 
histochemical techniques of hematoxilin and eosin (HE) and Grocott’s 
silver (GMS), as well special histochemical techniques such as Mayer’s 
mucicarmine (MM), which stains the capsule magenta, and Fontana-
Masson (FM), which stains fungal melanin reddish-brown1,12,13 .
In the Schwartz classification, infection is divided into two major 
histological categories, based upon reactions of the tissues24. The reactive 
pattern presents intense granulomatous inflammatory response, composed 
of macrophages, multinucleated giant cells, and lymphocytes5,13,24; the 
yeasts are found in an intracelullar location (phagocytozed)15,23. In the 
paucireactive pattern, yeasts are found extracellularly, associated to a 
minimal or absent inflammatory response, and tissue destruction results 
from compression necrosis by masses of cryptococcal tecidual6,23,24,26,27.
To evaluate the inflammatory response of Cryptococcus infections, 
two morphologic parameters are analyzed6,24. The viability of the 
organisms is estimated using the Carminophilic Index (CI), which 
indicates capsular synthesis. The divisional or mitotic activity of yeast is 
estimated by the Budding Index (BI), and indicates replication in vivo24.
This histopathological study has two main purposes: (a) to 
characterize the inflammatory response of Cryptococcus; (b) to show the 
relationship between CI and the titer of the antigen test, since capsule-
deficient strains may cause false-negative CrAg results.
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MATERIAL AND METHODS
A retrospective study was conduced by reviewing the medical records 
of patients who were diagnosed with cryptococcal infection based on 
histopathological identification, serological and cultures at the Micology 
Laboratory of Santa Casa Complexo Hospitalar (Porto Alegre, RS), in 
Southern Brazil. The data reviewed included age, gender, predisposing 
factors, host immune status, sites of infections, CrAg titer, and clinical 
presentation (localized or disseminated).
Culture: The identification of Cryptococcus was confirmed by the 
isolation of yeasts with white mucoid colonies (depending on the capsule 
thickness) after cultivation on fungal media (within 48-72 h), namely 
Sabouraud’s (SAB) at 25 °C, and brain-heart infusion (BHI) agar at 
35 °C; and by microscope by demonstrating the presence of spherical to 
oval yeast cells, budding on a narrow base, with a surrounding capsular 
structure. The species were discriminated by a color reaction when grown 
on canavanine-glycine-bromothymol blue (CGB) agar.
Analysis of microscopic pathology: Biopsy specimens were 
submitted to standard histological processing1. Tissue sections were 
stained by histochemical techniques of HE18 and GMS14,18, sections 
stained by special histochemical techniques of MM13,19 were also included. 
The histological reactions to HE2,24, the measurement of BI to GMS24, 
and the presence of magenta capsular structure12,13,19 and measurement of 
CI to MM stain24 were determined. Special histochemical techniques of 
FM stain13,17,18,19 were applied in those cases that showed negative results 
by the MM stain, and negative titers by the CrAg test. 
CrAg detection: The IMMY test - the commercial kit used in this 
study - has a vital component in Detacher Enzyme (DE), Pronase®. DE 
digests antibodies in immune complexes (the antigen is not affected), 
which can mask the detection of antigens. DE also eliminates the 
rheumatoid factor, that can cause false positives3,4.
RESULTS
Patients characteristics: During the 28-year period between 1980 
and 2008, there were 13 patients diagnosed with cryptococcosis based on 
histopathology, serology and cultures. Out of those, nine (70%) patients 
were men and four (30%) women. Their age ranged from 10 - 56 years 
old (average of 37.5 years). The median age was 36 years for men and 
41 for women. 
The majority of patients (77%) were considered to be 
immunocompromised with at least one identifiable risk factor, including 
infection with human immunodeficiency virus (HIV) in five (39%) 
patients, solid organ transplantation in four (31%) patients - renal (three 
Table 1
Histologic pattern, measurements of  BI and CI, CrAg titers and identification of Cryptococcus species complex in 13 patients
Cases Sex, Age Predisposing 
factors
Histologic pattern BI CI CrAg titers Specimen, CGBa
Immunocompetent
01 M, 10 None Reactive 
(Fibrotic nodules) 
(Cryptococcomas)
0 +++ 1:128 Cerebrospinal fluid, C. gattii
02* F, 42 None Reactive 15 0 Negative Axillary tumor biopsy, C. gattii
03 M, 56 None Reactive 12 ++++ 1:5112 Not done
Immunocompromised
04 M, 13 Tx pulmonary Paucireactive 
(Pulmonary 
nodules)
2 ++++ Negative Lung tissue biopsy, C. neoformans
05 M, 29 AIDS Paucireactive 4 +++ 1: 1049.536 Lymph node biopsy, C. neoformans
06 F, 30 AIDS Paucireactive 2 + 1:2 Not done
07 M, 31 AIDS Paucireactive 10 ++++ 1:5112 Cerebrospinal fluid, C. neoformans
08 M, 40 Tx  renal Reactive 3 + 1:8 Cutaneous tissue biopsy, C. 
neoformans
09 M, 42 AIDS Reactive 4 + 1:128 Not done
10* F, 42 Tx renal Reactive 5 0 Negative Not done
11* M, 50 AIDS Reactive 8 0 Negative Lung tissue biopsy, C. neoformans
12 F, 50 Tx  renal Paucireactive 3 +++ Negative Not done
13* M, 53 Immunosupres-
sive drugs
Reactive 2 0 Negative Lung tissue biopsy, C. neoformans
*, cases of capsule-deficient Cryptococcus infections; a, in 1 to 5 days, Cryptococcus gattii isolates turn the CGB medium blue, whereas those of Cryptococcus neofor-
mans do not; CGB, canavanine-glycine-bromothymol blue media; AIDS, acquired immunodeficiency syndrome; BI, budding index; CI, carminophilic index; CrAg: 
cryptococcal antigen; F, female; M, male; Tx, organ transplantation; Score employed for measurement of CI percentage 25% or less, +; 26% to 50%, ++; 51% to 75%, 
+++; 75%, ++++.
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cases) and lung (one case) - and user of immunosuppressive drugs in 
one (8%) patient. Three patients were considered immunocompetent: 
one presented infection by a capsule-deficient strain, one exhibited an 
axillary tumoral form, and the other one was a 10 year-old child.
A total of 30% (n = 4) presented localized pulmonary infection; all 
were HIV-uninfected. Disseminated infection was found in 70% (n = 
9); of these, 78% (n = 7) presented of the involvement central nervous 
system (CNS), these five were HIV-positive patients. Extraneural, 
extrapulmonary manifestations were observed in seven (54%) cases, 
including mediastinal lymphadenopathy (four cases), concomitant to 
oral cavity involvement (one case), hepatic (one case) and cutaneous 
(one case).
It was possible to identify the Cryptococcus species complex in 
eight cases: six (46%) cases of Cryptococcus neoformans and two 
(15%) cases of Cryptococcus gattii. All C. neoformans isolated were 
immunocompromised hosts; two C. gattii isolated were in apparently 
imunocompetent patients. As shown in Table 1, the Cryptococcus species 
were isolated on fungal media, namely SAB, BHI and CGB.
Histological pattern
Reactive: Circumscribed granulomas were seen in seven (54%) 
patients. The lesions were composed of compactly aggregated histiocytes 
and multinucleated giant cells, including both Langerhans and foreign 
body type, with numerous intracytoplasmatic yeasts (phagocytozed) (Fig. 
1A). Central area of necrosis associated to marginal fibrosis was observed 
(Fig. 1B). In one case, fibrotic nodules were identified. 
Paucireactive: Six (46%) cases presented numerous extracellular 
organisms, associated with a minimal to absent inflammatory response. 
Typical cells were spherical, oval, or ellipsoid, and surrounded by 
optically clear, smoothly spherical zones, or halos that are unstained 
capsules. In three (23%) cases chronic lymphadenitis were identified 
showing destruction of the architecture by compact masses of 
encapsulated yeasts (Fig. 1C). One case revealed organizing pneumonia. 
Table 1 summarizes the histologic patterns, measurements of CI and BI, 
and CrAg titers in 13 patients.
CI: Ranged from one-plus to four-plus (+ to ++++). Paucireactive 
pattern had the highest measurements of CI; the reactive pattern has 
shown marked variation among cases, ranging from one-plus to three-plus 
(+ to +++). A total of nine (70%) patients exhibited a magenta capsule 
stained by MM stain (cases 1, 3, 4, 5, 6, 7, 8, 9, 12) (Fig. 2A); four (30%) 
patients did not show a reactive carminophilic staining (cases 2, 10, 11, 
13); all presented the reactive pattern of the infection. 
BI: Both patterns showed great variation in this index (measurements 
0 to 15) (Fig. 2B).
CrAg test: Seven (54%) out of 13 patients had a positive serology, 
including samples from serum, cerebrospinal fluid and urine. Among those 
patients, the cases 1, 3, 5, 7 presented major measurements of CI. Of the 
six (46%) patients that presented negative results (cases 2, 4, 10, 11, 12, 
13), four (30%) did not show the presence of a carminophilic capsule after 
staining with MM thus preventing the measurements of CI (cases 2, 10, 
11, 13). Two (15%) transplant recipients presented localized pulmonary 
infection and showed negative results to the CRAg test (cases 4, 12).
Fontana-Masson stain: Cases 2, 10, 11, 13 did not show the 
presence of a mucicarminophilic capsule after staining with MM stain 
and presented negative results by CrAg test; in all cases the FM stain 
detected fungal melanin in the cell wall (Fig. 2C).
DISCUSSION
Before the AIDS epidemic, cryptococcosis was considered an unusual 
infection with low incidence rate6,23. After the recognition of AIDS, 
the diseases emerged as an important opportunistic infection16,20. The 
association with organ transplantation (four cases in our group) and use 
of immunosuppressive drugs has been established6,9,23.
Fig. 1 - Section of the lung stained with HE. Histologic patterns of cryptococcosis. A, 
multinucleated giant cell of foreign body type (case 2) (x100). B, granulomatous inflammation 
consisting of necrosis, macrophages, lymphocytes and fibroblastic activity (case 2) (x10). 
C, section of the lymph node with complete effacement of lymphoid tissue by compact 
extracellular yeasts (case 5) (x100).
Fig. 2 - A, section of the mediastinal lymph node stained with MM (x100). Organisms 
presented CI of ++++ with magenta capsule (case 3). B, section of the axillary tumoral form 
stained with GMS (x100). Organisms showing budding yeasts with a BI of 2 (case 6). C, 
section of the lung stained with FM (x100). Yeasts exhibited react positivelly for melanin 
fungal (case 13).
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Epidemiological analysis revealed a male predominance, with an 
average age similar to those in Colombia21 and France10. Among men 
and women, the average age showed differences in agreement with 
previous reports, suggesting that the average age is higher in women10,20. 
Although rarely, cryptococcosis can affect children8. In our sample, it was 
present in two children (15%). One was immunocompetent and lived in 
a biogeoclimatic endemic zone for Cryptococcus gattii in Brazil (Pará)8, 
and the other was a lung transplant recipient. 
Among organ systems, the respiratory tract is the most frequent 
site of entry involved6,16,22. The organism is trophic to the CNS, and 
the majority of cases were related to meningitis9,10, most commonly in 
HIV-positive patients. In contrast, pulmonary involvement was found 
to occur more frequently in HIV-negative patients. Cryptococcus may 
undergo hematogenous spread to other organ systems6,12. Extrapulmonary 
and extraneural manifestations were observed in 54% of patients. The 
following body sites are considered to be manifestations of disseminated 
disease: lymph node (lymphadenopathy), head and neck (involvement 
of oral cavity), skin and gastrointestines (hepatic)12,24.
C. gattii is likely to cause disease in healthy hosts and behaves as 
a primary pathogen, whereas C. neoformans affects predominantly 
immunocompromised individuals, especially those infected by HIV5,8,25. 
It is emphasized that the biopsy specimens should be in saline (0.9% 
NaCl) solution for fungal isolation, as well identification of species, since 
formalin fixation causes death of fungal agent preventing its growth on 
culture media.
Paucireactive cryptococcosis results from the impaired capability to 
successfully mount an effective inflammatory response. Cell-mediated 
immunity has a role in the defense mechanism24; in its absence, organisms 
proliferate extracellularly associated with destruction of tissue13,16,26. 
Histological analysis of our cases is consistent with these features. In 
the paucireactive infection, the BI varied greatly, and most cases showed 
less than 5% budding forms. When compared with the reactive infection, 
organisms showed highest measurements of CI. There is apparently an 
inverse correlation between capsular production and intense inflammatory 
responses6,24. 
A reactive pattern results in hosts having an active cell-mediated 
immune response24. The histology is characterized by a granulomatous 
response composed of histiocytes, giant cells, and lymphocytes associated 
with fibroblastic activity16,24,26,27,28. Our cases demonstrated these 
histologic features in different degrees. When compared to paucireactive 
infection, the yeasts cells were less abundant, and both CI and BI showed 
a greater spectrum of variation. 
The fibrotic nodules, better known as the cryptococcomas, represent 
an infection in immunocompetent persons24. Similar lesions are presented 
in histoplasmosis24 and tuberculosis24,28. Case 1 contained scarce 
organisms having a CI of +++ and BI of zero.
The CrAg were first described by BLOOMFIELD et al.4 in the sera 
and cerebrospinal fluid (CSF) of seven from a total of nine patients. 
The CrAg test is approximately 95% sensitive and specific3. False-
negative results reported were due to a poorly encapsulated strain6,23. 
Although commercial kits differ, the CrAg test detects at least 10 ng 
of polysaccharide per mL of biological fluid6. These false-negatives 
are due to capsular deficiency as this strain does not produce enough 
polysaccharides antigens to be detected by the CrAg test. In fact, the 
size of the polysaccharides of cells of the deficient-capsule strain is 
smaller than those of the typical strain. Patients with primary pulmonary 
cryptococcosis without dissemination may have false-negative serum 
tests, since yeasts have not yet disseminated from the lung. Once antigen 
is detected in the serum of a patient with cryptococcosis, this is a sign 
that infection has disseminated from its pulmonary location6. On the basis 
of these observations, in false-negative titers and unsatisfactory staining 
results by MM stain, the special techniques of the FM stain for fungal 
melanin confirm infections by capsule-deficient Cryptococcus strains.
RESUMO
Histopatologia, sorologia e cultivo no diagnóstico da criptococose
A criptococose é a mais comum infecção fúngica oportunística 
observada em pacientes com síndrome da imunodeficiência adquirida 
(AIDS). Relatamos 13 casos da infecção baseados no diagnóstico 
histopatológico, sorológico e cultivo. Foram analisadas: a epidemiologia, 
as técnicas histoquímicas básicas de hematoxilina-eosina (HE) e 
coloração pela prata (GMS), bem como as técnicas histoquímicas 
especiais de mucicarmim de Mayer (MM) e Fontana-Masson (FM), 
o teste do antígeno criptocóccico (CrAg) e o isolamento em cultivos 
em ágar-Sabouraud (SAB), ágar infusão de cérebro-coração (BHI) e 
meio com canavanina azul de bromotimol (CGB). Em quatro casos, 
resultados tintoriais insatisfatórios pela coloração de MM associados 
a títulos negativos pelo teste do CrAg, a coloração de FM confirmou a 
infecção pelo Cryptococcus deficiente de cápsula. Oito isolados foram 
identificados: seis casos apresentaram a infecção por Cryptococcus 
neoformans e dois casos apresentaram a infecção por Cryptococcus gattii.
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